富祥药业：目前三氮唑新工艺他唑巴坦产品顺利完成下游客户合格供应商备案

Core Viewpoint - Company is a major global supplier of tazobactam and has successfully completed the qualification process for downstream customers, which will enhance production capacity and market competitiveness [1] Group 1: Product Supply and Market Position - Company is the largest global supplier of sulbactam and the only domestic supplier certified by international standards, with sulbactam products currently experiencing a price increase [1] - Company is expanding the production capacity of piperacillin, which can be combined with tazobactam and sulbactam to form compound preparations, indicating a broad market demand [1] Group 2: Production Cost and Innovation - Company is one of the few domestic manufacturers with a full industry chain layout for carbapenem products, and the market price for carbapenem products is at a historical low, with limited room for further price declines [1] - Company is collaborating with a research team to develop a continuous flow enzyme method, which is expected to reduce the cost of carbapenem products by 15%-20% [1]